Paths of Genetic and Environmental Influence:The Routes Connecting Personality Disorders with Substance Use Disorders

2005 ◽  
pp. 31-53
Author(s):  
Remi J. Cadoret ◽  
Douglas Langbehn ◽  
Edward Troughton ◽  
Rebecca Yucuis
Keyword(s):  
Substance Use ◽  
Personality Disorders ◽  
Substance Use Disorders

Substance Use Disorders, Personality Disorders, and Eating Disorders

2016 ◽  
pp. 711-714
Author(s):  
Brian A. Palmer
Keyword(s):  
Eating Disorders ◽  
Substance Use ◽  
Personality Disorders ◽  
Substance Use Disorders ◽  
Prescription Drugs ◽  
Psychotic Symptoms ◽  
Drug Induced ◽  
Medical Settings ◽  
Generic Term ◽  
And Behavior

Psychosis is a generic term used to describe altered thought and behavior in which the patient is incapable of interpreting his or her situation rationally and accurately. Psychotic symptoms can occur in various medical, neurologic, and psychiatric disorders. Many psychotic reactions seen in medical settings are associated with the use of recreational or prescription drugs. Some of these drug-induced psychotic reactions are nearly indistinguishable from schizophrenia in terms of hallucinations and paranoid delusions.

Co-Occurrence of Personality Disorders with Mood, Anxiety, and Substance use Disorders in a Young Adult Population

2006 ◽  
Vol 20 (1) ◽  
pp. 102-112 ◽  
Author(s):  
Liisa Kantojärvi ◽  
Juha Veijola ◽  
Kristian Läksy ◽  
Jari Jokelainen ◽  
Anne Herva ◽  
...  
Keyword(s):  
Substance Use ◽  
Young Adult ◽  
Personality Disorders ◽  
Substance Use Disorders ◽  
Adult Population ◽  
Young Adult Population

scholarly journals Prevalence, Comorbidity, and Sociodemographic Correlates of Psychiatric Disorders in the All Of Us Biobank

2021 ◽  
Author(s):  
Peter B. Barr ◽  
Tim B. Bigdeli ◽  
Jacquelyn M. Meyers
Keyword(s):  
Substance Use ◽  
Anxiety Disorders ◽  
Personality Disorders ◽  
Psychiatric Disorders ◽  
Substance Use Disorders ◽  
Low Socioeconomic Status ◽  
Large Scale ◽  
Demographic Correlates ◽  
Sociodemographic Correlates ◽  
Demographic Covariates

ABSTRACTImportanceAll of Us is a landmark initiative for population-scale research into the etiology of psychiatric disorders and disparities across various sociodemographic categories.ObjectiveTo estimate the prevalence, comorbidity, and demographic covariates of psychiatric and substance use disorders in the All of Us biobank.Design, Setting, and ParticipantsWe estimated prevalence, overlap, and demographic correlates for psychiatric disorders derived from electronic health records in the All of Us biobank (release 5; N = 331,380)ExposuresSocial and demographic covariates.Main Outcome and MeasuresPsychiatric disorders derived from ICD10CM codes and grouped into phecodes across six broad domains: mood disorders, anxiety disorders, substance use disorders, stress-related disorders, schizophrenia, and personality disorders.ResultsThe prevalence of various disorders ranges from approximately 15% to less than 1%, with mood and anxiety disorders being the most common, followed by substance use disorders, stress-related disorders, schizophrenia, and personality disorders. There is substantial overlap among disorders, with a large portion of those with a disorder (~57%) having two or more registered diagnoses and tetrachoric correlations ranging from 0.43 – 0.74. The prevalence of disorders across demographic categories demonstrates that non-Hispanic whites, those of low socioeconomic status, women and those assigned female at birth, and sexual minorities are at greatest risk for most disorders.Conclusions and RelevanceAlthough the rates of disorders in All of Us are lower than rates for disorders in the general population, there is considerable variation, comorbidity, and differences across social groups. Large-scale resources like All of Us will prove to be invaluable for understanding the causes and consequences of psychiatric conditions. As we move towards an era of precision medicine, we must work to ensure it is delivered in an equitable manner.

Cause-specific mortality in Swedish males diagnosed with non-psychotic mental disorders in late adolescence: a prospective population-based study

2018 ◽  
Vol 72 (7) ◽  
pp. 582-588 ◽  
Author(s):  
Malin Henriksson ◽  
Jenny Nyberg ◽  
Linus Schiöler ◽  
Gunnel Hensing ◽  
Georg H Kuhn ◽  
...  
Keyword(s):  
Mental Illness ◽  
Substance Use ◽  
Personality Disorders ◽  
Substance Use Disorders ◽  
Proportional Hazards ◽  
Cox Proportional Hazards ◽  
Adjustment Disorders ◽  
Late Adolescent ◽  
Related Substance ◽  
Specific Mortality

BackgroundWhile risk of premature death is most pronounced among persons with severe mental illness, also milder conditions are associated with increased all-cause mortality. We examined non-psychotic mental (NPM) disorders and specific causes of natural death in a cohort of late adolescent men followed for up to 46 years.MethodsProspective cohort study of Swedish males (n=1 784 626) who took part in structured conscription interviews 1968–2005. 74 525 men were diagnosed with NPM disorders at or prior to conscription. Median follow-up time was 26 years. HRs for cause-specific mortality were calculated using Cox proportional hazards models.ResultsRisks in fully adjusted models were particularly elevated for death by infectious diseases (depressive and neurotic/adjustment disorders (HR 2.07; 95% CI 1.60 to 2.67), personality disorders (HR 2.90; 95% CI 1.96 to 4.28) and alcohol-related and other substance use disorders (HR 9.02; 95% CI 6.63 to 12.27)) as well as by gastrointestinal causes (depressive and neurotic/adjustment disorders (HR 1.64; 95% CI 1.42 to 1.89), personality disorders (HR 2.77; 95% CI 2.27 to 3.38) and alcohol-related/substance use disorders (HR 4.41; 95% CI 3.59 to 5.42)).ConclusionYoung men diagnosed with NPM disorders had a long-term increased mortality risk, in particular due to infectious and gastrointestinal conditions. These findings highlight the importance of early preventive actions for adolescents with mental illness.

Cognitive Therapy for Comorbid Depression

2014 ◽  
Author(s):  
Mark A. Whisman ◽  
Daniel BE
Keyword(s):  
Substance Use ◽  
Anxiety Disorders ◽  
Personality Disorders ◽  
Cognitive Therapy ◽  
Substance Use Disorders ◽  
Clinical Guidelines ◽  
Clinical Samples ◽  
Comorbid Depression ◽  
Axis Ii ◽  
Axis I

Depression often co-occurs with other Axis I and Axis II psychiatric disorders. This chapter presents a model for how cognitive therapy (CT) of depression can be adapted in conceptualizing and treating the complex set of issues and problems that often accompany comorbid depression. It begins with a discussion of the prevalence of comorbidity in community and clinical samples, then review the research on comorbidity and outcome to CT for depression, followed by a model for adapting or modifying CT for patients who present with depression and a comorbid Axis I or Axis II disorder. The chapter concludes with specific clinical guidelines for treating depression that co-occurs with anxiety disorders, substance use disorders, and personality disorders.

Sign in / Sign up

Export Citation Format

Share Document